Modulation of hepatocyte nuclear factor-4alpha function by the peroxisome-proliferator-activated receptor-gamma co-activator-1alpha in the acute-phase response.

Modulation of hepatocyte nuclear factor-4alpha function by the peroxisome-proliferator-activated receptor-gamma co-activator-1alpha in the acute-phase response.
复制标题

DOI:
10.1042/bj20080355
复制
发表时间:
2008-10-15
期刊:
The Biochemical journal
影响因子:
--
通讯作者:
Burke PA
Burke PA
中科院分区:
其他
文献类型:
--
作者:
Wang Z;Burke PA

文献摘要

被引文献

相似文献

HNF-4α(hepatocyte nuclear factor-4α)是肝脏特异性基因表达的关键调节因子。为了解HNF-4α在急性期反应(APR)中的调控机制,在损伤细胞模型中研究了转录共激活因子p300、PGC-1α(过氧化物酶体增殖物激活受体γ共激活因子1α)和SRC-1 α(类固醇受体共激活因子)的作用。我们先前已经证明,HNF-4α敏感性APR基因Apo B(载脂蛋白B)、TTR(甲状腺素运载蛋白)和α1-AT(α1-抗胰蛋白酶)在细胞因子刺激后在DNA结合和转录水平上受到调节。我们现在发现,共激活因子通过ApoB、TTR或α1-AT启动子中的HNF-4α结合位点对HNF-4α敏感基因的反式激活具有不同的影响。PGC-1α强烈增强ApoB和α1-AT的反式激活,并在较小程度上增强TTR的反式激活,而SRC-1α和p300仅对这三个基因有微弱或无影响。更重要的是,发现PGC-1α在响应细胞因子处理的HNF-4α结合能力的调节中具有新的作用。通过体外和体内的方法,电泳迁移率变化和染色质免疫沉淀试验,我们证明了细胞因子诱导的HNF-4α-DNA结合能力的降低可以通过PGC-1α的过表达而消除。细胞因子处理不会显著改变HNF-4α和PGC-1α的蛋白水平,但它确实减少了PGC-1α向HNF-4α结合位点的募集,从而降低了转录活性。这些结果确立了PGC-1α对HNF-4α功能的重要性,并描述了一种新的HNF-4α依赖性调节机制,参与了对损伤的反应。
HNF-4α (hepatocyte nuclear factor-4α) is a key regulator of liver-specific gene expression. To understand the mechanisms governing the regulation of HNF-4α function during the APR (acute-phase response), the effects of transcription co-activators, including p300, PGC-1α (peroxisome-proliferator-activated receptor-γ co-activator-1α) and SRC (steroid receptor co-activator)-1α were investigated in an injury cell model. We have shown previously that the HNF-4α-sensitive APR genes ApoB (apolipoprotein B), TTR (transthyretin) and α1-AT (α1-antitrypsin) were regulated at the DNA binding and transcriptional levels after cytokine stimulation. We now show that co-activators have a differential impact on the transactivation of HNF-4α-sensitive genes via HNF-4α-binding sites in ApoB, TTR or α1-AT promoters. PGC-1α strongly enhances the transactivation of ApoB and α1-AT and, to a lesser extent, of TTR, whereas SRC-1α and p300 only have a weak or no effect on these three genes. More importantly, it was found that PGC-1α has a novel role in the modulation of the binding ability of HNF-4α in response to cytokine treatment. Using in vitro and in vivo approaches, electrophoretic mobility-shift and chromatin immunoprecipitation assays, we demonstrate that the reduced HNF-4α-DNA binding ability induced by cytokines is eliminated by overexpression of PGC-1α. Cytokine treatment does not significantly alter the protein levels of HNF-4α and PGC-1α, but it does reduce the recruitment of PGC-1α to HNF-4α-binding sites and thereby decreases transcriptional activity. These results establish the importance of PGC-1α for HNF-4α function and describe a new HNF-4α-dependent regulatory mechanism that is involved in the response to injury.